Variation in antibiotic use for children hospitalized with inflammatory bowel disease exacerbation: A multicenter validation study

Journal of the Pediatric Infectious Diseases Society

Volumn 1, Issue 4, 2012, Pages 306-313

  Kronman, Matthew P ^a   Gerber, Jeffrey S ^b   Prasad, Priya A ^b   Adler, Amanda L ^a   Bass, Julie A ^c   Newland, Jason G ^c   Shah, Kavisha M ^c   Zerr, Danielle M ^a   Feng, Rui ^b   Coffin, Susan E ^b   Zaoutis, Theoklis E ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Epidemiology; Inflammatory bowel disease; Variation

Indexed keywords

ADALIMUMAB; AMPICILLIN; AZATHIOPRINE; CIPROFLOXACIN; CYCLOSPORIN; GENTAMICIN; HYDROCORTISONE; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; PREDNISOLONE;

ABDOMINAL ABSCESS; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ARTHRITIS; CHILD; CLOSTRIDIUM DIFFICILE; COHORT ANALYSIS; DISEASE EXACERBATION; DRUG USE; ENDOSCOPY; FEMALE; FISTULA; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; PERIANAL ABSCESS; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VALIDATION STUDY;

EID: 84898720660     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pis053     Document Type: Article

References (31)

1. Malaty HM, Fan X, Opekun AR, Thibodeaux C, Ferry GD. Rising incidence of inflammatory bowel disease among children: a 12-year study. J Pediatr Gastroenterol Nutr 2010; 50:27-31.
2. Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13:254-261.
3. Shanahan F, Bernstein CN. The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 2009; 25: 301-305.
4. Bousvaros A, Sylvester F, Kugathasan S, et al. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:885-913.
5. Kappelman MD, Porter CQ, Galanko JA, et al. Utilization of healthcare resources by US children and adults with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17:62-68.
6. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134:577-594.
7. West RL, van der Woude CJ, Hansen BE, et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a doubleblind placebo-controlled study. Aliment Pharmacol Ther 2004; 20:1329-1336.
8. Prantera C, Lochs H, Campieri M, et al. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther 2006; 23:1117-1125.
9. Thia KT, Mahadevan U, Feagan BG, et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebocontrolled pilot study. Inflamm Bowel Dis 2009; 15:17-24.
10. Maeda Y, Ng SC, Durdey P, et al. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease. Br J Surg 2010; 97:1340-1347.
11. Mantzaris GJ, Archavlis E, Christoforidis P, et al. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Am J Gastroenterol 1997; 92:454-456.
12. Turunen UM, Farkkila MA, Hakala K, et al. Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study. Gastroenterology 1998; 115:1072-1078.
13. Mantzaris GJ, Petraki K, Archavlis E, et al. A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis. Scand J Gastroenterol 2001; 36:971-974.
14. Ohkusa T, Kato K, Terao S, et al. Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial. Am J Gastroenterol 2010; 105:1820-1829.
15. Khan KJ, Ullman TA, Ford AC, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011; 106:661-673.
16. Huang J, Liao C, Wu L, Cao Y, Gao F. A meta-analysis of randomized controlled trials comparing antibacterial therapy with placebo in Crohn's disease. Colorectal Dis 2011; 13:617-626.
17. Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 2010; 16:112-124.
18. Sandborn WJ, Feagan BG, Lichtenstein GR. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission. Aliment Pharmacol Ther 2007; 26:987-1003.
19. Perencevich M, Burakoff R. Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 651-664.
20. Kappelman MD, Bousvaros A, Hyams J, et al. Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis 2007; 13:890-895.
21. Esrailian E, Spiegel BM, Targownik LE, Dubinsky MC, Targan SR, Gralnek IM. Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes. Aliment Pharmacol Ther 2007; 26:1005-1018.
22. Colletti RB, Baldassano RN, Milov DE, et al. Variation in care in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2009; 49:297-303.
23. Kappelman MD, Palmer L, Boyle BM, Rubin DT. Quality of care in inflammatory bowel disease: a review and discussion. Inflamm Bowel Dis 2010; 16:125-133.
24. Spellberg B, Guidos R, Gilbert D, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:155-164.
25. Weiss PF, Klink AJ, Hexem K, et al. Variation in inpatient therapy and diagnostic evaluation of children with Henoch Schonlein purpura. J Pediatr 2009; 155:812-818.e1.
26. Gerber JS, Newland JG, Coffin SE, et al. Variability in antibiotic use at children's hospitals. Pediatrics 2010; 126: 1067-1073.
27. Feudtner C, Levin JE, Srivastava R, et al. How well can hospital readmission be predicted in a cohort of hospitalized children? A retrospective, multicenter study. Pediatrics 2009; 123: 286-293.
28. Normand SLT, Shahian DM. Statistical and clinical aspects of hospital outcomes profiling. Stat Sci 2007; 22:206-226.
29. Benchimol EI, Guttmann A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 2009; 58:1490-1497.
30. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991; 12:439-447.
31. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007; 133: 423-432.